News

Filter

Current filters:

Fulvestrant

1 to 9 of 29 results

AZ's Faslodex improves disease control

22-12-2008

New data show for the first time that high-dose treatment with AstraZeneca's Faslodex (fulvestrant) 500mg…

AnastrozoleArimidexAstraZenecaFaslodexFulvestrant

High dose Faslodex impresses in breast cancer trial

24-12-2007

New data presented at this year's San Antonio Breast Cancer Symposium indicate that a high-dose regimen…

AstraZenecaFaslodexFulvestrant

Pfizer data indicates differences between steroidal and non-steroidal aromatase inhibitors

26-03-2007

In a presentation at the 10th International Conference on Adjuvant Therapy of Primary Breast Cancer in…

AromasinExemestaneFaslodexFulvestrantPfizer

Strong data for AstraZeneca's Faslodex

22-12-2006

Anglo-Swedish drug major AstraZeneca says that the first results from the EFECT trial, presented at the…

AromasinAstraZenecaExemestaneFaslodexFulvestrantPfizer

Faslodex as advanced breast cancer drug

13-03-2006

Data from a Phase II study of Anglo-Swedish drugmaker AstraZeneca's anticancer drug Faslodex (fulvestrant),…

AnastrozoleArimidexAromasinAstraZenecaExemestaneFaslodexFemaraFulvestrantLetrozoleNovartis

AstraZeneca's Faslodex and Arimidex little different

19-12-2005

Analysis of two Phase III studies evaluating the time to response of Faslodex (fulvestrant) injection…

Amino AcidsAnastrozoleArimidexAstraZenecaFaslodexFulvestrantInjectionNystatinOralPhysostigmine Salicylate

AstraZeneca's Faslodex meets unmet need in breast cancer

29-03-2004

Faslodex (fulvestrant), the first new estrogen receptor antagonist since tamoxifen, has finally been…

Amino AcidsAnastrozoleArimidexAstraZenecaEstraceEstradiolEvamistFaslodexFulvestrantInjectionPhysostigmine Salicylate

1 to 9 of 29 results

Back to top